|15. Switch to a monoclonal antibody TNFi biologic over a TNFi biologic soluble receptor biologic (i.e., etanercept) (PICO 58)|Moderate (115â€“117)|
|Strong recommendation supported by moderate-quality evidence, showing TNFi monoclonal antibody biologics are effective in IBD but indirect evidence shows a TNFi biologic soluble receptor biologic is not effective for the treatment of IBD.|Strong recommendation supported by moderate-quality evidence, showing TNFi monoclonal antibody biologics are effective in IBD but indirect evidence shows a TNFi biologic soluble receptor biologic is not effective for the treatment of IBD.|
|16. Switch to a TNFi monoclonal antibody biologic over an IL-17i biologic (PICO 59)|Moderate (50)|